Page 1 of Clinical Trials for Double Blind Randomization, 32575 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms
Last Updated: February 21, 2012
Condition(s): Schizophrenia and Predominant Negative Symptoms
2
Completed
A Trial of the C-Tb Skin Test, When Given Intradermally to Healthy Volunteers Previously Vaccinated With BCG
Last Updated: February 8, 2012
Condition(s): Tuberculosis
3
Completed
A Trial of the C-Tb Skin Test, When Given Intradermally to Adult Patients Recently Diagnosed With Active Tuberculosis (TB)
Last Updated: February 8, 2012
Condition(s): Tuberculosis
4
Active, not recruiting
Letrozole in Treating Women With Primary Breast Cancer Who Have Received 5 Years of Aromatase Inhibitor Therapy
Last Updated: May 15, 2012
Condition(s): Breast Cancer
5
Terminated
L-Arginine Treatment for Severe Vascular Fetal Intrauterine Growth Restriction: a Randomized Double Bind Controlled Trial (L Arginine in IUGR)
Last Updated: October 25, 2007
Condition(s): Intra Uterine Growth Retardation
6
Completed
Phase I Study to Evaluate the Safety and Immunogenicity of HIV-1 Immunogen in Children With HIV-1 Infection
Last Updated: March 3, 2008
Condition(s): HIV Infection
7
Completed
In Vivo Quantification of Dental Demineralisation Using Optical Coherence Tomography Before and After Double-blind, Randomised Treatment With Esomeprazole or Placebo of Patients With Dental Erosions
Last Updated: February 1, 2012
Condition(s): Tooth Erosion
8
Recruiting
Effect of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthritis
Last Updated: December 15, 2011
Condition(s): Uveitis; Juvenile Arthritis
9
Active, not recruiting
Impact of Mulberry Leaf on Type 2 Diabetes
Last Updated: January 15, 2010
Condition(s): Type 2 Diabetes
10
Recruiting
Pharmacogenetic Response to Naltrexone For Alcohol Dependence
Last Updated: August 4, 2011
Condition(s): Alcohol Dependence
11
Recruiting
Citicoline Treatment of Methamphetamine Dependence
Last Updated: April 19, 2012
Condition(s): Methamphetamine Dependence
12
Terminated
A Randomized, Double-Blind, Placebo-Controlled Study to Examine the Effect of Betahistine on Plasma Lipids in Patients Treated With Simvastatin
Last Updated: September 24, 2007
Condition(s): Hypercholesterolemia
13
Terminated
A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Last Updated: February 23, 2012
Condition(s): Depressive Disorder, Major; Depression
14
Completed
A Randomized, Active-controlled, Double-blind, Parallel-Goup Study of the Efficacy and Safety of Extended Release(ER) Paliperidone in the Treatment of Schizophrenia
Last Updated: May 18, 2011
Condition(s): Acute Schizophrenia
15
Active, not recruiting
A Phase III Randomized, Double Blind, Placebo Controlled Multi-center Study of Panobinostat for Maintenance of Response in Patients With Hodgkin's Lymphoma
Last Updated: May 3, 2011
Condition(s): Hodgkin's Lymphoma
16
Withdrawn
On Label, Randomized, Double-Blind, Placebo-Controlled Trial of Preoperative Finasteride in Patients Undergoing Transurethral Resection of the Prostate (TURP)
Last Updated: November 4, 2009
Condition(s): Benign Prostatic Hyperplasia
17
Completed
Double-blind, Randomized, Placebo-controlled Phase 3 Study of Etanercept in the Treatment of Psoriatic Arthritis and Psoriasis
Last Updated: December 22, 2010
Condition(s): Psoriatic Arthritis; Psoriasis
18
Active, not recruiting
Rifaximin Plus Lactulose Versus Lactulose Alone for the Treatment of Hepatic Encephalopathy: a Double Blind Randomized Trial
Last Updated: November 27, 2011
Condition(s): Hepatic Encephalopathy
19
Terminated
A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Last Updated: February 23, 2012
Condition(s): Depressive Disorder; Depression
20
Recruiting
Darbepoetin Alfa in Anemic Low or Intermediate-1 Risk MDS Subjects
Last Updated: April 30, 2012
Condition(s): MDS

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Double+Blind+Randomization

Page 1 of Clinical Trials for Double Blind Randomization, 32575 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About